{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T05:10:19Z","timestamp":1725426619413},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2001,3,1]],"date-time":"2001-03-01T00:00:00Z","timestamp":983404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>T-helper cell responses to HIV have been associated with protection against maternal-infant HIV transmission in the absence of antiretroviral treatment, but the effects of antiretroviral treatment, now widely used for prevention, on development of these cell-mediated responses is unknown. We tested whether development of T-helper cell responses to HIV and other antigens would be affected by exposure to short-course regimens of zidovudine-lamivudine (ZDV-3TC) given to prevent maternal-infant HIV transmission. Cord blood samples were collected from 41 infants of HIV-infected mothers enrolled in a clinical trial in which they were treated with regimens of ZDV-3TC and from 29 infants whose HIV-infected mothers were not treated with any antiretroviral drugs. T-helper cell reactivity to HIV envelope peptides and other antigens was measured in vitro using a sensitive culture supernatant titration assay based on IL-2-dependent proliferation. Infants in the clinical trial were followed to 18\u2003months to determine their HIV infection status, and venous blood samples were re-tested at 4\u00b75 and 9\u2003months for T-cell reactivity to HIV. HIV-stimulated T-helper cell reactivity in cord blood was detected 10-fold less frequently among those exposed to antiretroviral prophylaxis (2\u00b74%) than among those unexposed (24\u00b71%) (P\u2003=\u20030\u00b7007). Reductions in HIV-stimulated responses in cord blood occurred despite detectable HIV RNA (mean 3\u00b738 standard deviation 0\u00b776 log10 copies per ml) at delivery among treated women and occurred independent of treatment duration. Our results suggest that short-course antiretroviral treatment given to prevent maternal-infant HIV transmission may attenuate HIV-stimulated T-cell memory responses in the neonate.<\/jats:p>","DOI":"10.1046\/j.1365-2249.2001.01460.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T10:26:15Z","timestamp":1047378375000},"page":"443-450","source":"Crossref","is-referenced-by-count":15,"title":["Reduced HIV-stimulated T-helper cell reactivity in cord blood with short-course antiretroviral treatment for prevention of maternal\u2013infant transmission"],"prefix":"10.1093","volume":"123","author":[{"given":"L","family":"Kuhn","sequence":"first","affiliation":[{"name":"Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Division of Epidemiology, &#x2028;Joseph L. Mailman School of Public Health, Columbia University, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Meddows-Taylor","sequence":"additional","affiliation":[{"name":"AIDS Virus Research Unit, &#x2028;National Institute for Virology, Johannesburg, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Gray","sequence":"additional","affiliation":[{"name":"Perinatal HIV Research Unit, Chris Hani-Baragwanath Hospital, Soweto, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Trabattoni","sequence":"additional","affiliation":[{"name":"Cattedra di Immunologia, Universita degli Studi di Milano, Milan, Italy and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Clerici","sequence":"additional","affiliation":[{"name":"Cattedra di Immunologia, Universita degli Studi di Milano, Milan, Italy and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G M","family":"Shearer","sequence":"additional","affiliation":[{"name":"Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Tiemessen","sequence":"additional","affiliation":[{"name":"AIDS Virus Research Unit, &#x2028;National Institute for Virology, Johannesburg, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,7,7]]},"reference":[{"key":"2022011221102015600_b1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0167-5699(96)80564-0","article-title":"Protective immunity against HIV infection: has nature done the experiment for us?","volume":"17","author":"Shearer","year":"1996","journal-title":"Immunol Today"},{"issue":"Suppl. 2","key":"2022011221102015600_b2","first-page":"S143","article-title":"HIV type 1-specific helper T cells: a critical host defense","volume":"14","author":"Rosenberg","year":"1998","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2022011221102015600_b3","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/infdis\/165.6.1012","article-title":"Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1","volume":"165","author":"Clerici","year":"1992","journal-title":"J Infect Dis"},{"key":"2022011221102015600_b4","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/infdis\/173.2.472","article-title":"Human immunodeficiency virus type 1 (HIV-1) -seronegative injection drug users at risk for HIV exposure have antibodies to HLA class I antigens and T cells specific for HIV envelop","volume":"173","author":"Beretta","year":"1996","journal-title":"J Infect Dis"},{"key":"2022011221102015600_b5","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/nm1197-1250","article-title":"HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals","volume":"3","author":"Mazzoli","year":"1997","journal-title":"Nature Med"},{"key":"2022011221102015600_b6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nm0195-59","article-title":"HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women","volume":"1","author":"Rowland-Jones","year":"1996","journal-title":"Nature Med"},{"key":"2022011221102015600_b7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00002030-199901140-00004","article-title":"HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers","volume":"13","author":"Kaul","year":"1999","journal-title":"AIDS"},{"key":"2022011221102015600_b8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/jama.1994.03510250058035","article-title":"HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood","volume":"271","author":"Clerici","year":"1994","journal-title":"JAMA"},{"key":"2022011221102015600_b9","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1172\/JCI117085","article-title":"Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients","volume":"93","author":"Langlade-Demoyen","year":"1994","journal-title":"J Clin Invest"},{"key":"2022011221102015600_b10","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1172\/JCI118133","article-title":"ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids","volume":"96","author":"Pinto","year":"1995","journal-title":"J Clin Invest"},{"key":"2022011221102015600_b11","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/0140-6736(93)93063-7","article-title":"HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant","volume":"341","author":"Rowland-Jones","year":"1993","journal-title":"Lancet"},{"key":"2022011221102015600_b12","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/eji.1830220905","article-title":"Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers","volume":"22","author":"Cheynier","year":"1992","journal-title":"Eur J Immunol"},{"key":"2022011221102015600_b13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2249.1994.tb06580.x","article-title":"Cytotoxic T lymphocyte activity and CD8 subpopulations in children at risk of HIV infection","volume":"97","author":"Aldhous","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"2022011221102015600_b14","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/infdis\/170.5.1296","article-title":"Occurrence of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T cell activity in apparently uninfected children born to HIV-1-infected mothers","volume":"170","author":"De Maria","year":"1994","journal-title":"J Infect Dis"},{"key":"2022011221102015600_b15","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/infdis\/170.4.766","article-title":"High frequency of Gag- and envelope-specific cytotoxic T lymphocyte precursors in children with vertically acquired human immunodeficiency virus type 1 infection","volume":"170","author":"Mcfarland","year":"1994","journal-title":"J Infect Dis"},{"key":"2022011221102015600_b16","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0022-3476(05)80732-2","article-title":"Deficient human immunodeficiency virus type 1-specific cytotoxic T cell responses in vertically infected children","volume":"119","author":"Luzuriaga","year":"1991","journal-title":"J Pediatr"},{"key":"2022011221102015600_b17","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.4049\/jimmunol.162.7.4355","article-title":"Protective role of B-chemokines associated with HIV-specific Th responses against perinatal HIV transmission","volume":"162","author":"Wasik","year":"1999","journal-title":"J Immunol"},{"key":"2022011221102015600_b18","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1097\/00002030-199311000-00004","article-title":"Cellular immune factors associated with mother-to-infant transmission of HIV","volume":"7","author":"Clerici","year":"1993","journal-title":"AIDS"},{"key":"2022011221102015600_b19","author":"Kuhn"},{"key":"2022011221102015600_b20","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(98)10411-7","article-title":"Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomized controlled trial","volume":"353","author":"Shaffer","year":"1999","journal-title":"Lancet"},{"key":"2022011221102015600_b21","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(98)10412-9","article-title":"Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, C\u00f4te D'Ivoire: a randomized trial","volume":"353","author":"Wiktor","year":"1999","journal-title":"Lancet"},{"key":"2022011221102015600_b22","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(98)11046-2","article-title":"6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breast fed children in C\u00f4te d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial","volume":"353","author":"Dabis","year":"1999","journal-title":"Lancet"},{"key":"2022011221102015600_b23","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJM199611283352201","article-title":"Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant","volume":"335","author":"Sperling","year":"1996","journal-title":"N Engl J Med"},{"key":"2022011221102015600_b24","article-title":"Results of the PETRA intervention trial to prevent perinatal transmission in sub-Saharan Africa","volume-title":"6th Conference on Retroviruses and Opportunistic Infections","author":"Saba","year":"1999"},{"key":"2022011221102015600_b25","article-title":"The PETRA study: early and late efficacy of three short ZDV\/3TC combination regimens to prevent mother-to-child transmission of HIV-1","volume-title":"XIII International AIDS Conference","author":"Gray","year":"2000"},{"key":"2022011221102015600_b26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/339383a0","article-title":"Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals","volume":"339","author":"Clerici","year":"1989","journal-title":"Nature"},{"key":"2022011221102015600_b27","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/infdis\/164.1.178","article-title":"Exposure to human immunodeficiency virus type 1-specific T helper cell responses before detection of infection by polymerase chain reaction and serum antibodies","volume":"164","author":"Clerici","year":"1991","journal-title":"J Infect Dis"},{"key":"2022011221102015600_b28","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1172\/JCI115389","article-title":"Construction of peptides encompassing multideterminant clusters of human immunodeficiency virus envelope to induce in vitro T cell responses in mice and humans of multiple MHC types","volume":"88","author":"Berzofsky","year":"1991","journal-title":"J Clin Invest"},{"key":"2022011221102015600_b29","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/intimm\/1.4.409","article-title":"T cell multideterminant regions in the human immunodeficiency virus envelop: toward overcoming the problem of major histocompatibility complex restriction","volume":"1","author":"Hale","year":"1989","journal-title":"Int Immunol"},{"key":"2022011221102015600_b30","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1073\/pnas.84.12.4249","article-title":"Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelop protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide","volume":"84","author":"Cease","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011221102015600_b31","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1172\/JCI116526","article-title":"Analysis of T helper and antigen-presenting cell functions in cord blood and peripheral blood leukocytes from healthy children of different ages","volume":"91","author":"Clerici","year":"1993","journal-title":"J Clin Invest"},{"key":"2022011221102015600_b32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00002030-200001280-00005","article-title":"Different immunologic profiles characterize HIV infection in highly active antiretroviral therapy-treated and antiretroviral-naive patients with undetectable viraemia","volume":"14","author":"Clerici","year":"2000","journal-title":"AIDS"},{"key":"2022011221102015600_b33","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.4049\/jimmunol.120.6.2027","article-title":"cell growth factor: Parameters of production and a quantitative microassay for activity","volume":"120","author":"Gillis","year":"1978","journal-title":"J Immunol"},{"key":"2022011221102015600_b34","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/268154a0","article-title":"Long-term culture of tumor-specific cytotoxic T cells","volume":"268","author":"Gillis","year":"1977","journal-title":"Nature"},{"key":"2022011221102015600_b35","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1086\/314431","article-title":"Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspring","volume":"178","author":"Moodley","year":"1998","journal-title":"J Infect Dis"},{"key":"2022011221102015600_b36","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1086\/314628","article-title":"The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses","volume":"179","author":"Markowitz","year":"1999","journal-title":"J Infect Dis"},{"key":"2022011221102015600_b37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00002030-199301000-00020","article-title":"Administration of zidovudine during primary HIV-1 infection may be associated with a less vigorous immune response","volume":"7","author":"Tindall","year":"1993","journal-title":"AIDS"},{"key":"2022011221102015600_b38","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0167-5699(99)01473-5","article-title":"T-cell function in newborn mice and humans","volume":"20","author":"Adkins","year":"1999","journal-title":"Immunol Today"},{"key":"2022011221102015600_b39","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/00002030-199410000-00004","article-title":"T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques","volume":"8","author":"Clerici","year":"1994","journal-title":"AIDS"},{"key":"2022011221102015600_b40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0198-8859(97)00202-4","article-title":"Analysis of neonatal T cell and antigen presenting cell functions","volume":"57","author":"Trivedi","year":"1997","journal-title":"Human Immunol"},{"key":"2022011221102015600_b41","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1086\/501646","article-title":"Effect of zidovudine postexposure prophylaxis on the development of HIV-specific cytotoxic T-lymphocyte responses in HIV-exposed healthcare workers","volume":"20","author":"D'Amico","year":"1999","journal-title":"Infect Control Hospital Epidemiol"},{"key":"2022011221102015600_b42","first-page":"131","article-title":"Differential effect of azidothymidine on resting and activated cells: Potentiality of this drug for treatment of post-transfusion graft-versus-host disease","volume":"100","author":"Nishimura","year":"1998","journal-title":"Res Comm Mol Pathol Pharmacol"},{"key":"2022011221102015600_b43","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/00002030-199905280-00008","article-title":"Rapid disease progression in HIV-1 perinatally infected children born to mothers receiving zidovudine monotherapy during pregnacy","volume":"13","author":"Italian Registry for HIV Infection in Children.","year":"1999","journal-title":"AIDS"},{"key":"2022011221102015600_b44","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1086\/315678","article-title":"Disease progression and early viral dynamics in HIV-infected children exposed to zidovudine during the pre- and peri-natal period","volume":"182","author":"Kuhn","year":"2000","journal-title":"J Infect Dis"},{"key":"2022011221102015600_b45","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/S0140-6736(99)04388-3","article-title":"15-month efficacy of maternal oral zidovudine to decrease vertical transmission of HIV-1 in breastfed African children","volume":"354","author":"Ditrame","year":"1999","journal-title":"Lancet"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2249.2001.01460.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2249.2001.01460.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/123\/3\/443\/42135962\/j.1365-2249.2001.01460.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/123\/3\/443\/42135962\/j.1365-2249.2001.01460.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T23:59:11Z","timestamp":1682121551000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/123\/3\/443\/6461476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2008,7,7]]},"published-print":{"date-parts":[[2008,7,7]]}},"URL":"https:\/\/doi.org\/10.1046\/j.1365-2249.2001.01460.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2001,3]]},"published":{"date-parts":[[2001,3]]}}}